首页 > 最新文献

JAR life最新文献

英文 中文
Temporal muscle thickness predicts change in nutritional markers in individuals at risk of dementia: Insights from a 24-week longitudinal study. 颞肌厚度预测痴呆风险个体营养指标的变化:来自24周纵向研究的见解。
Pub Date : 2025-08-08 eCollection Date: 2025-01-01 DOI: 10.1016/j.jarlif.2025.100023
Salomón Salazar-Londoño, Valeria Pérez-Foucrier, Jonathan Patricio Baldera, Markus Aarsland, Luis Carlos Venegas-Sanabria, Miguel German Borda

Objectives: To investigate whether temporal muscle thickness (TMT) can serve as a predictor of change in nutritional widely used biomarkers in patients at risk of dementia.

Design: Longitudinal observational study.

Setting: Secondary analysis from a 24-week study conducted across three centers in Norway between 2018 and 2020.

Participants: Patients with mild cognitive impairment (MCI) or with two cardiometabolic disorders were included (n = 165).

Measurements: Baseline and longitudinal statistical analysis were carried out to establish the association for outcomes (albumin, weight, C-Reactive Protein and Episodic Memory Quality) with TMT.

Results: At baseline, there was a positive association between TMT and weight (Estimate=1.5157, p = 0.009). At follow-up, positive associations were observed between TMT and albumin levels (Estimate=0.3031, P = 0.048), as well as TMT and weight (Estimate=1.8954, P = 0.001).

Conclusion: TMT is a possible accessible tool in clinical practice for monitoring health variables beyond cognitive decline in patients at risk of dementia.

目的:研究颞肌厚度(TMT)是否可以作为痴呆风险患者营养广泛使用的生物标志物变化的预测因子。设计:纵向观察研究。环境:2018年至2020年期间在挪威三个中心进行的为期24周的研究的二次分析。参与者:包括轻度认知障碍(MCI)或两种心脏代谢障碍的患者(n = 165)。测量方法:进行基线和纵向统计分析,以确定结果(白蛋白、体重、c反应蛋白和情景记忆质量)与TMT的关联。结果:在基线时,TMT与体重呈正相关(估计值=1.5157,p = 0.009)。随访时,TMT与白蛋白水平呈正相关(估计值=0.3031,P = 0.048), TMT与体重呈正相关(估计值=1.8954,P = 0.001)。结论:TMT在临床实践中可能是一种可获得的工具,用于监测痴呆风险患者认知能力下降以外的健康变量。
{"title":"Temporal muscle thickness predicts change in nutritional markers in individuals at risk of dementia: Insights from a 24-week longitudinal study.","authors":"Salomón Salazar-Londoño, Valeria Pérez-Foucrier, Jonathan Patricio Baldera, Markus Aarsland, Luis Carlos Venegas-Sanabria, Miguel German Borda","doi":"10.1016/j.jarlif.2025.100023","DOIUrl":"10.1016/j.jarlif.2025.100023","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate whether temporal muscle thickness (TMT) can serve as a predictor of change in nutritional widely used biomarkers in patients at risk of dementia.</p><p><strong>Design: </strong>Longitudinal observational study.</p><p><strong>Setting: </strong>Secondary analysis from a 24-week study conducted across three centers in Norway between 2018 and 2020.</p><p><strong>Participants: </strong>Patients with mild cognitive impairment (MCI) or with two cardiometabolic disorders were included (<i>n</i> = 165).</p><p><strong>Measurements: </strong>Baseline and longitudinal statistical analysis were carried out to establish the association for outcomes (albumin, weight, C-Reactive Protein and Episodic Memory Quality) with TMT.</p><p><strong>Results: </strong>At baseline, there was a positive association between TMT and weight (Estimate=1.5157, <i>p</i> = 0.009). At follow-up, positive associations were observed between TMT and albumin levels (Estimate=0.3031, <i>P</i> = 0.048), as well as TMT and weight (Estimate=1.8954, <i>P</i> = 0.001).</p><p><strong>Conclusion: </strong>TMT is a possible accessible tool in clinical practice for monitoring health variables beyond cognitive decline in patients at risk of dementia.</p>","PeriodicalId":73537,"journal":{"name":"JAR life","volume":"14 ","pages":"100023"},"PeriodicalIF":0.0,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12357314/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144877143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alterations of the oral microbiota in mild Alzheimer's disease and the appropriate application of chlorhexidine gluconate. 轻度阿尔茨海默病口腔微生物群的改变和葡萄糖酸氯己定的适当应用。
Pub Date : 2025-08-05 eCollection Date: 2025-01-01 DOI: 10.1016/j.jarlif.2025.100024
Huizhen Cao, Jiangming Zhong, Lili Chen

Objective: This study investigated the effect of 0.2 % chlorhexidine gluconate on oral microbiota dysbiosis in Alzheimer's disease (AD) and explored potential links between oral microbiota and cognition, offering new insights into its role in AD treatment.

Study design: We assessed the impact of 0.2 % chlorhexidine gluconate on the oral microbiota of patients with AD. One hundred patients were divided into two groups based on oral health score (using a cut-off of 8). Subgingival plaque samples were analyzed using 16S rRNA sequencing; no significant differences in bacterial composition were observed between groups at baseline.

Results: Poor oral health correlated with higher oral health scores (P = 0.000), fewer teeth (P = 0.002), lower cognitive levels (P = 0.048), and a higher proportion of patients with diabetes (P = 0.032). After 24 weeks of treatment with 0.2 % chlorhexidine gluconate in a randomized controlled trial, subgingival plaques from 66 patients showed changes in Porphyromonas, Filifactor, Desulfobulbus, Anaeroglobus, Pyramidobacter, Mycoplasma, Dialister, Fretibacterium, and Tannerella (P < 0.05). Treponema and Porphyromonas gingivalis were identified as potential interventional targets.

Conclusion: Chlorhexidine gluconate effectively alters oral flora, reducing harmful bacteria. Targeting specific microbiota disturbances may offer a promising strategy to delay AD onset or slow its progression.

Trial registration: This research was registered with the Chinese Clinical Trial Registry (ChiCTR; Reference: ChiCTR2000032876). Registered: 14th of May 2020; http://www.chictr.org.cn/showprojen.aspx?proj=53555.

目的:研究0.2%葡萄糖酸氯己定对阿尔茨海默病(AD)口腔微生物群失调的影响,探讨口腔微生物群与认知之间的潜在联系,为其在AD治疗中的作用提供新的见解。研究设计:我们评估0.2%葡萄糖酸氯己定对AD患者口腔微生物群的影响。100例患者根据口腔健康评分分为两组(截止值为8)。采用16S rRNA测序对龈下菌斑样本进行分析;在基线时,两组之间的细菌组成没有显著差异。结果:口腔健康状况较差与口腔健康评分较高(P = 0.000)、牙齿较少(P = 0.002)、认知水平较低(P = 0.048)、糖尿病患者比例较高(P = 0.032)相关。在一项随机对照试验中,给予0.2%葡萄糖酸氯己定治疗24周后,66例患者龈下斑块出现卟啉单胞菌、Filifactor、Desulfobulbus、厌氧红蛋白、锥体杆菌、支原体、Dialister、Fretibacterium和Tannerella的变化(P < 0.05)。密螺旋体和牙龈卟啉单胞菌被确定为潜在的干预靶点。结论:葡萄糖酸氯己定能有效改变口腔菌群,减少有害细菌。针对特定的微生物群紊乱可能提供一种有希望的策略来延缓阿尔茨海默病的发病或减缓其进展。试验注册:本研究已在中国临床试验注册中心(ChiCTR;参考:ChiCTR2000032876)。注册日期:2020年5月14日;http://www.chictr.org.cn/showprojen.aspx?proj=53555。
{"title":"Alterations of the oral microbiota in mild Alzheimer's disease and the appropriate application of chlorhexidine gluconate.","authors":"Huizhen Cao, Jiangming Zhong, Lili Chen","doi":"10.1016/j.jarlif.2025.100024","DOIUrl":"10.1016/j.jarlif.2025.100024","url":null,"abstract":"<p><strong>Objective: </strong>This study investigated the effect of 0.2 % chlorhexidine gluconate on oral microbiota dysbiosis in Alzheimer's disease (AD) and explored potential links between oral microbiota and cognition, offering new insights into its role in AD treatment.</p><p><strong>Study design: </strong>We assessed the impact of 0.2 % chlorhexidine gluconate on the oral microbiota of patients with AD. One hundred patients were divided into two groups based on oral health score (using a cut-off of 8). Subgingival plaque samples were analyzed using 16S rRNA sequencing; no significant differences in bacterial composition were observed between groups at baseline.</p><p><strong>Results: </strong>Poor oral health correlated with higher oral health scores (<i>P</i> = 0.000), fewer teeth (<i>P</i> = 0.002), lower cognitive levels (<i>P</i> = 0.048), and a higher proportion of patients with diabetes (<i>P</i> = 0.032). After 24 weeks of treatment with 0.2 % chlorhexidine gluconate in a randomized controlled trial, subgingival plaques from 66 patients showed changes in <i>Porphyromonas, Filifactor, Desulfobulbus, Anaeroglobus, Pyramidobacter, Mycoplasma, Dialister, Fretibacterium,</i> and <i>Tannerella</i> (<i>P</i> < 0.05). <i>Treponem</i>a and <i>Porphyromonas gingivalis</i> were identified as potential interventional targets.</p><p><strong>Conclusion: </strong>Chlorhexidine gluconate effectively alters oral flora, reducing harmful bacteria. Targeting specific microbiota disturbances may offer a promising strategy to delay AD onset or slow its progression.</p><p><strong>Trial registration: </strong>This research was registered with the Chinese Clinical Trial Registry (ChiCTR; Reference: ChiCTR2000032876). Registered: 14th of May 2020; http://www.chictr.org.cn/showprojen.aspx?proj=53555.</p>","PeriodicalId":73537,"journal":{"name":"JAR life","volume":"14 ","pages":"100024"},"PeriodicalIF":0.0,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344254/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144850028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Food insecurity among older persons in the Southern African Development Community: a scoping review. 南部非洲发展共同体老年人的粮食不安全:范围审查。
Pub Date : 2025-08-05 eCollection Date: 2025-01-01 DOI: 10.1016/j.jarlif.2025.100021
Finn Hartwell-Kinnear

Despite the heterogenous challenges of growing older in low- and middle-income settings, there is a deficiency of research explicating food insecurity among older persons. Given rapid population ageing in Sub-Saharan Africa, alongside worsening deprivation, this paper offers an interrogation of existing evidence and exposes concomitant shortfalls in the knowledgebase. Scoping review methodology was employed using PRISMA Guidelines which systematically searched and screened three academic databases. At the global level, climate shifts and natural disasters, pandemics and epidemics such as Coronavirus-2019 and HIV/AIDS affect food insecurity. At a national level, food and welfare systems play a comparatively well-researched role in food insecurity among older persons. Community factors; levels of self-mobilisation or actions of civil society, and intrahousehold dynamics of kinship and associated resource distribution also proved important variables in determining food insecurity. Finally, demographic characteristics; age, marital status, gender, physical and cognitive abilities and coping mechanisms are discussed. In critical review, the work identifies two salient shortcomings in the understanding of food insecurity among older persons. One, extant research fails to account for path dependency, either within the lives of older persons, or socio-economic and political structures surrounding them. The findings, therefore, call for greater impetus upon the adoption of a life-course perspective. Two, scholars have failed to acknowledge older persons' role in shaping these structures and the food/welfare matrix at large. The work concludes by advocating for further theoretical development toward a comprehensive political economy of food insecurity, accounting for changes in the life-course of the individual, and the food, family and welfare systems in which they find themselves.

尽管在低收入和中等收入环境中老年人面临着各种各样的挑战,但缺乏解释老年人粮食不安全问题的研究。考虑到撒哈拉以南非洲的人口快速老龄化,以及日益恶化的贫困,本文对现有证据进行了质疑,并暴露了知识库中随之而来的不足。使用PRISMA指南采用范围审查方法,该指南系统地检索和筛选了三个学术数据库。在全球层面,气候变化和自然灾害、2019冠状病毒和艾滋病毒/艾滋病等流行病和流行病影响着粮食不安全。在国家一级,粮食和福利制度在老年人粮食不安全问题上的作用得到了比较充分的研究。社会因素;民间社会的自我动员或行动水平,以及家庭内部亲属关系和相关资源分配的动态,也被证明是决定粮食不安全的重要变量。最后是人口特征;讨论了年龄、婚姻状况、性别、身体和认知能力以及应对机制。在严格审查中,这项工作确定了对老年人粮食不安全的认识存在两个突出缺陷。首先,现有的研究没有考虑到老年人生活中的路径依赖,也没有考虑到他们周围的社会经济和政治结构。因此,调查结果要求更大力度地推动采用生命历程观点。第二,学者们没有认识到老年人在塑造这些结构和食物/福利矩阵中的作用。最后,本书主张进一步发展粮食不安全的综合政治经济学理论,解释个人生命历程的变化,以及他们所处的粮食、家庭和福利制度。
{"title":"Food insecurity among older persons in the Southern African Development Community: a scoping review.","authors":"Finn Hartwell-Kinnear","doi":"10.1016/j.jarlif.2025.100021","DOIUrl":"10.1016/j.jarlif.2025.100021","url":null,"abstract":"<p><p>Despite the heterogenous challenges of growing older in low- and middle-income settings, there is a deficiency of research explicating food insecurity among older persons. Given rapid population ageing in Sub-Saharan Africa, alongside worsening deprivation, this paper offers an interrogation of existing evidence and exposes concomitant shortfalls in the knowledgebase. Scoping review methodology was employed using PRISMA Guidelines which systematically searched and screened three academic databases. At the global level, climate shifts and natural disasters, pandemics and epidemics such as Coronavirus-2019 and HIV/AIDS affect food insecurity. At a national level, food and welfare systems play a comparatively well-researched role in food insecurity among older persons. Community factors; levels of self-mobilisation or actions of civil society, and intrahousehold dynamics of kinship and associated resource distribution also proved important variables in determining food insecurity. Finally, demographic characteristics; age, marital status, gender, physical and cognitive abilities and coping mechanisms are discussed. In critical review, the work identifies two salient shortcomings in the understanding of food insecurity among older persons. One, extant research fails to account for path dependency, either within the lives of older persons, or socio-economic and political structures surrounding them. The findings, therefore, call for greater impetus upon the adoption of a life-course perspective. Two, scholars have failed to acknowledge older persons' role in shaping these structures and the food/welfare matrix at large. The work concludes by advocating for further theoretical development toward a comprehensive political economy of food insecurity, accounting for changes in the life-course of the individual, and the food, family and welfare systems in which they find themselves.</p>","PeriodicalId":73537,"journal":{"name":"JAR life","volume":"14 ","pages":"100021"},"PeriodicalIF":0.0,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344261/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144850029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The associations between pretreatment neutrophil-to-lymphocyte ratio, sarcopenia and frailty in older patients with head and neck cancer. 老年头颈癌患者预处理中性粒细胞与淋巴细胞比率、肌肉减少症和虚弱之间的关系
Pub Date : 2025-08-05 eCollection Date: 2025-01-01 DOI: 10.1016/j.jarlif.2025.100022
C D A Meerkerk, M H Emmelot-Vonk, S Haitjema, R de Bree

Background: Performing a Geriatric Assessment (GA) is recommended to help guiding treatment decisions in vulnerable older patients. As a full GA is time consuming and expensive, frailty screening methods are worth investigating. Sarcopenia and the neutrophil-to-lymphocyte ratio (NLR) could be easily available biomarkers related to frailty.

Objectives: We investigated the relationships between NLR, sarcopenia, and frailty, and assessed the potential of NLR as a frailty screening method in older patients with head and neck cancer (HNC). In addition, the relationship between the NLR and each GA item was investigated.

Design: Retrospective study.

Participants and measurements: 148 older (≥ 60 years) patients with HNC who had undergone pretreatment a GA, routine blood sample, handgrip strength (HGS) and head and neck CT or MRI for skeletal muscle mass measurement (SMM). The GA to determine frailty was assessed as outcome. Sarcopenia was defined as the combination of low SMM and low HGS.

Results: The mean age was 70 (6.08 SD) years. A total of 95 (64 %) patients had an elevated NLR and 21 (14 %) had sarcopenia. Based on the GA, 56 (38 %) patients were determined as frail. Patients with an elevated NLR were more likely to be frail and sarcopenic compared to patients with a normal NLR. NLR score showed a significant though weak correlation with frailty (r= - 0.287, p < 0.05). Using GA as reference standard, the sensitivity, specificity, positive predictive value, negative predictive value and accuracy to predict frailty for NLR were 83 %, 47 %, 49 %, 83 % and 61 %, respectively. In multivariate regression analysis, the significant predictors for frailty were comorbidity, skeletal muscle index (SMI), and NLR. For elevated NLR, SMI and frailty were predictors. Elevated NLR was associated with nutritional status (OR 3.56, P = 0.02) and comorbidity (OR 3.81, P = 0.02) as independent GA items.

Conclusion: Increased NLR is frequently observed in older HNC patients, often in combination with low SMI and frailty. There is a significant correlation between NLR and frailty. However, the accuracy of NLR to predict frailty based on GA is limited.

背景:建议进行老年评估(GA),以帮助指导易受伤害的老年患者的治疗决策。由于一个完整的遗传是耗时和昂贵的,虚弱筛查方法值得研究。肌少症和中性粒细胞与淋巴细胞比值(NLR)是与虚弱相关的容易获得的生物标志物。目的:我们研究了NLR、肌肉减少症和虚弱之间的关系,并评估了NLR作为老年头颈癌(HNC)患者虚弱筛查方法的潜力。此外,研究了NLR与GA各项目之间的关系。设计:回顾性研究。参与者和测量:148例老年(≥60岁)HNC患者接受了预处理,包括GA、常规血液样本、握力(HGS)和头颈部CT或MRI骨骼肌质量测量(SMM)。确定虚弱的GA被评估为结果。肌少症定义为低SMM和低HGS的结合。结果:患者平均年龄70岁(6.08 SD)。共有95例(64%)患者NLR升高,21例(14%)患者肌肉减少症。基于GA, 56例(38%)患者被确定为虚弱。与NLR正常的患者相比,NLR升高的患者更容易虚弱和肌肉减少。NLR评分与脆性呈显著但微弱的相关(r= - 0.287, p < 0.05)。以GA为参考标准,预测NLR脆性的敏感性为83%,特异性为47%,阳性预测值为49%,阴性预测值为83%,准确性为61%。在多变量回归分析中,衰弱的显著预测因子是合并症、骨骼肌指数(SMI)和NLR。对于NLR升高,重度精神障碍和虚弱是预测因子。NLR升高与营养状况(OR 3.56, P = 0.02)和合并症(OR 3.81, P = 0.02)作为独立的GA项目相关。结论:在老年HNC患者中经常观察到NLR增加,通常合并低SMI和虚弱。NLR与脆弱性之间存在显著相关。然而,基于遗传算法的NLR预测脆弱性的准确性有限。
{"title":"The associations between pretreatment neutrophil-to-lymphocyte ratio, sarcopenia and frailty in older patients with head and neck cancer.","authors":"C D A Meerkerk, M H Emmelot-Vonk, S Haitjema, R de Bree","doi":"10.1016/j.jarlif.2025.100022","DOIUrl":"10.1016/j.jarlif.2025.100022","url":null,"abstract":"<p><strong>Background: </strong>Performing a Geriatric Assessment (GA) is recommended to help guiding treatment decisions in vulnerable older patients. As a full GA is time consuming and expensive, frailty screening methods are worth investigating. Sarcopenia and the neutrophil-to-lymphocyte ratio (NLR) could be easily available biomarkers related to frailty.</p><p><strong>Objectives: </strong>We investigated the relationships between NLR, sarcopenia, and frailty, and assessed the potential of NLR as a frailty screening method in older patients with head and neck cancer (HNC). In addition, the relationship between the NLR and each GA item was investigated.</p><p><strong>Design: </strong>Retrospective study.</p><p><strong>Participants and measurements: </strong>148 older (≥ 60 years) patients with HNC who had undergone pretreatment a GA, routine blood sample, handgrip strength (HGS) and head and neck CT or MRI for skeletal muscle mass measurement (SMM). The GA to determine frailty was assessed as outcome. Sarcopenia was defined as the combination of low SMM and low HGS.</p><p><strong>Results: </strong>The mean age was 70 (6.08 SD) years. A total of 95 (64 %) patients had an elevated NLR and 21 (14 %) had sarcopenia. Based on the GA, 56 (38 %) patients were determined as frail. Patients with an elevated NLR were more likely to be frail and sarcopenic compared to patients with a normal NLR. NLR score showed a significant though weak correlation with frailty (<i>r</i>= - 0.287, <i>p</i> < 0.05). Using GA as reference standard, the sensitivity, specificity, positive predictive value, negative predictive value and accuracy to predict frailty for NLR were 83 %, 47 %, 49 %, 83 % and 61 %, respectively. In multivariate regression analysis, the significant predictors for frailty were comorbidity, skeletal muscle index (SMI), and NLR. For elevated NLR, SMI and frailty were predictors. Elevated NLR was associated with nutritional status (OR 3.56, <i>P</i> = 0.02) and comorbidity (OR 3.81, <i>P</i> = 0.02) as independent GA items.</p><p><strong>Conclusion: </strong>Increased NLR is frequently observed in older HNC patients, often in combination with low SMI and frailty. There is a significant correlation between NLR and frailty. However, the accuracy of NLR to predict frailty based on GA is limited.</p>","PeriodicalId":73537,"journal":{"name":"JAR life","volume":"14 ","pages":"100022"},"PeriodicalIF":0.0,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12717774/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How many sites are enough? a novel, site-based power analysis method for real-world registry studies of anti-amyloid monoclonal antibodies. 多少个站点才足够?一种新的、基于位点的功效分析方法,用于抗淀粉样蛋白单克隆抗体的真实世界注册研究。
Pub Date : 2025-07-22 eCollection Date: 2025-01-01 DOI: 10.1016/j.jarlif.2025.100020
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, Atsushi Iwata, Takeshi Iwatsubo

Background: Real-world registries ALZ-NET (US) and AD-DMT (Japan) support safety surveillance of anti-amyloid antibodies. Conventional power calculations-dividing required patients by mean per-site caseload-can underestimate the number of centers needed because of patient counts variability.

Objectives: To develop and evaluate a simulation-based method for site-level sample size planning that incorporates inter-site variability.

Design: We developed a simulation using a zero-truncated negative binomial model to reflect caseload heterogeneity. We estimated the required sites (k) to achieve a target precision (95 % confidence interval [CI] width) for ARIA incidence under random and volume-weighted sampling, based on data from published trials. The required number of sites was determined as the point where the CI width met a prespecified precision target (< 0.1).

Setting: Simulated ALZ-NET and AD-DMT registry settings using prevalence and ARIA frequencies from published lecanemab and donanemab trials.

Measurements: Precision (95 % CI width) for estimating ARIA incidence in APOE-ε4 homozygotes; comparison of required site counts as estimated by the three methods.

Results: Under random sampling, our method's site requirement (∼320 sites) was consistent with the ICC-adjusted method, whereas the conventional method underestimated the need (∼220 sites). Critically, our framework showed that strategic volume-weighted sampling could reduce the requirement to as few as 110 sites, surpassing the efficiency of the static analytical methods.

Conclusions: Conventional methods risk underestimating site requirements by ignoring caseload heterogeneity. Our simulation framework provides more realistic estimates and, crucially, quantifies the substantial efficiency gains from strategic recruitment, serving as a flexible tool to optimize registry design.

背景:现实世界的注册机构ALZ-NET(美国)和AD-DMT(日本)支持抗淀粉样蛋白抗体的安全性监测。传统的功率计算——将需要的病人除以每个站点的平均病例量——由于病人数量的可变性,可能低估了需要的中心数量。目的:开发和评估一种基于模拟的方法,用于纳入站点间可变性的站点级样本量规划。设计:我们开发了一个使用零截断负二项模型来反映病例负荷异质性的模拟。根据已发表的试验数据,我们估计了在随机和体积加权抽样下ARIA发生率达到目标精度(95%置信区间[CI]宽度)所需的位点(k)。所需的位点数被确定为CI宽度满足预定精度目标(< 0.1)的点。设置:模拟ALZ-NET和AD-DMT注册设置,使用来自发表的lecanemab和donanemab试验的患病率和ARIA频率。测量方法:用于估计APOE-ε4纯合子ARIA发生率的精度(95% CI宽度);比较三种方法估计的所需场地数量。结果:在随机抽样的情况下,我们的方法的位点需求(~ 320个位点)与icc调整方法一致,而传统方法低估了需求(~ 220个位点)。关键的是,我们的框架表明,战略性体积加权抽样可以将需求减少到110个站点,超过了静态分析方法的效率。结论:传统方法忽视病例负荷异质性,有低估现场需求的风险。我们的模拟框架提供了更现实的估计,并且至关重要的是,量化了战略招聘的实质性效率收益,作为优化注册表设计的灵活工具。
{"title":"How many sites are enough? a novel, site-based power analysis method for real-world registry studies of anti-amyloid monoclonal antibodies.","authors":"Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, Atsushi Iwata, Takeshi Iwatsubo","doi":"10.1016/j.jarlif.2025.100020","DOIUrl":"10.1016/j.jarlif.2025.100020","url":null,"abstract":"<p><strong>Background: </strong>Real-world registries ALZ-NET (US) and AD-DMT (Japan) support safety surveillance of anti-amyloid antibodies. Conventional power calculations-dividing required patients by mean per-site caseload-can underestimate the number of centers needed because of patient counts variability.</p><p><strong>Objectives: </strong>To develop and evaluate a simulation-based method for site-level sample size planning that incorporates inter-site variability.</p><p><strong>Design: </strong>We developed a simulation using a zero-truncated negative binomial model to reflect caseload heterogeneity. We estimated the required sites (k) to achieve a target precision (95 % confidence interval [CI] width) for ARIA incidence under random and volume-weighted sampling, based on data from published trials. The required number of sites was determined as the point where the CI width met a prespecified precision target (< 0.1).</p><p><strong>Setting: </strong>Simulated ALZ-NET and AD-DMT registry settings using prevalence and ARIA frequencies from published lecanemab and donanemab trials.</p><p><strong>Measurements: </strong>Precision (95 % CI width) for estimating ARIA incidence in <i>APOE</i>-ε4 homozygotes; comparison of required site counts as estimated by the three methods.</p><p><strong>Results: </strong>Under random sampling, our method's site requirement (∼320 sites) was consistent with the ICC-adjusted method, whereas the conventional method underestimated the need (∼220 sites). Critically, our framework showed that strategic volume-weighted sampling could reduce the requirement to as few as 110 sites, surpassing the efficiency of the static analytical methods.</p><p><strong>Conclusions: </strong>Conventional methods risk underestimating site requirements by ignoring caseload heterogeneity. Our simulation framework provides more realistic estimates and, crucially, quantifies the substantial efficiency gains from strategic recruitment, serving as a flexible tool to optimize registry design.</p>","PeriodicalId":73537,"journal":{"name":"JAR life","volume":"14 ","pages":"100020"},"PeriodicalIF":0.0,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304769/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144746337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physical activity for health across the lifespan: A call to action. 终生体育锻炼促进健康:行动呼吁。
Pub Date : 2025-07-11 eCollection Date: 2025-01-01 DOI: 10.1016/j.jarlif.2025.100019
Brianna Leadbetter, Danielle R Bouchard
{"title":"Physical activity for health across the lifespan: A call to action.","authors":"Brianna Leadbetter, Danielle R Bouchard","doi":"10.1016/j.jarlif.2025.100019","DOIUrl":"10.1016/j.jarlif.2025.100019","url":null,"abstract":"","PeriodicalId":73537,"journal":{"name":"JAR life","volume":"14 ","pages":"100019"},"PeriodicalIF":0.0,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12274859/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144676749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The relationship between symptoms of depression and falls in older adults: A case-control study. 老年人抑郁症状与跌倒之间的关系:一项病例对照研究
Pub Date : 2025-07-10 eCollection Date: 2025-01-01 DOI: 10.1016/j.jarlif.2025.100018
Manizheh Moshtaghi, Sadegh Kargarian-Marvasti, Pouya Farokhnezhad Afshar, Seyedeh Melika Kharghani Moghaddam, Fatemeh Bahramnezhad

Background: Fall is one of the most common and severe syndromes of older adults that causes disability. Depression is one of the disorders that can lead to many problems, but the results have been contradictory.

Objectives: This study aimed to determine the relationship between symptoms of depression and falls in older adults.

Design: This observational study.

Setting: We collected the data from the health records of older adults in comprehensive health service centers.

Participants: We selected two groups of older adults (60 years and above) as the case group (400 older adults with a history of falling) and the control group (400 older adults without a history of falling).

Measurements: The history of falling was based on the report of old people during a month ago. Symptoms of Depression has been assessed using the Goldberg General Health Questionnaire (GHQ-28).

Results: 62.5 % of the sample were old women. The elderly males were 74.6 ± 0.47 years, and the elderly women were 72.9 ± 0.34 years. There was no significant relationship between symptoms of depression and falls in older adults (OR = 1.321, P = 0.203). Age (over 75 years) (OR = 4.391, P < 0.001) and living alone (OR = 2.924, P < 0.001), and high school education (OR = 3.947, P = 0.008) are risk factors.

Conclusions: The symptoms of depression are not related to falls in older adults. However, being above 75 years old and living alone increases the risk of falls, and higher education reduces the risk of falls.

背景:跌倒是导致老年人残疾的最常见和最严重的综合征之一。抑郁症是可能导致许多问题的疾病之一,但结果是矛盾的。目的:本研究旨在确定老年人抑郁症状与跌倒之间的关系。设计:本观察性研究。背景:我们收集综合卫生服务中心老年人的健康记录。参与者:我们选择了两组老年人(60岁及以上)作为病例组(400名有跌倒史的老年人)和对照组(400名没有跌倒史的老年人)。测量方法:跌倒史以老年人一个月前的报告为依据。使用Goldberg一般健康问卷(GHQ-28)评估抑郁症状。结果:老年妇女占62.5%。老年男性74.6±0.47岁,老年女性72.9±0.34岁。老年人抑郁症状与跌倒无显著相关性(OR = 1.321, P = 0.203)。年龄(75岁以上)(OR = 4.391, P < 0.001)、独居(OR = 2.924, P < 0.001)、高中学历(OR = 3.947, P = 0.008)是危险因素。结论:老年人抑郁症状与跌倒无关。然而,75岁以上独居会增加跌倒的风险,而受过高等教育则会降低跌倒的风险。
{"title":"The relationship between symptoms of depression and falls in older adults: A case-control study.","authors":"Manizheh Moshtaghi, Sadegh Kargarian-Marvasti, Pouya Farokhnezhad Afshar, Seyedeh Melika Kharghani Moghaddam, Fatemeh Bahramnezhad","doi":"10.1016/j.jarlif.2025.100018","DOIUrl":"10.1016/j.jarlif.2025.100018","url":null,"abstract":"<p><strong>Background: </strong>Fall is one of the most common and severe syndromes of older adults that causes disability. Depression is one of the disorders that can lead to many problems, but the results have been contradictory.</p><p><strong>Objectives: </strong>This study aimed to determine the relationship between symptoms of depression and falls in older adults.</p><p><strong>Design: </strong>This observational study.</p><p><strong>Setting: </strong>We collected the data from the health records of older adults in comprehensive health service centers.</p><p><strong>Participants: </strong>We selected two groups of older adults (60 years and above) as the case group (400 older adults with a history of falling) and the control group (400 older adults without a history of falling).</p><p><strong>Measurements: </strong>The history of falling was based on the report of old people during a month ago. Symptoms of Depression has been assessed using the Goldberg General Health Questionnaire (GHQ-28).</p><p><strong>Results: </strong>62.5 % of the sample were old women. The elderly males were 74.6 ± 0.47 years, and the elderly women were 72.9 ± 0.34 years. There was no significant relationship between symptoms of depression and falls in older adults (OR = 1.321, <i>P</i> = 0.203). Age (over 75 years) (OR = 4.391, <i>P</i> < 0.001) and living alone (OR = 2.924, <i>P</i> < 0.001), and high school education (OR = 3.947, <i>P</i> = 0.008) are risk factors.</p><p><strong>Conclusions: </strong>The symptoms of depression are not related to falls in older adults. However, being above 75 years old and living alone increases the risk of falls, and higher education reduces the risk of falls.</p>","PeriodicalId":73537,"journal":{"name":"JAR life","volume":"14 ","pages":"100018"},"PeriodicalIF":0.0,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12274764/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144676750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multidomain interventions for preventing cognitive decline in older adults with type 2 diabetes and mild cognitive impairment: Secondary analysis of the J-MINT: Multidomain intervention in type 2 diabetes. 预防老年2型糖尿病和轻度认知障碍患者认知能力下降的多领域干预:J-MINT的二次分析:2型糖尿病的多领域干预
Pub Date : 2025-06-09 eCollection Date: 2025-01-01 DOI: 10.1016/j.jarlif.2025.100016
Taiki Sugimoto, Paul K Crane, Seo-Eun Choi, Kosuke Fujita, Jeanne Gallée, Yujiro Kuroda, Michael Lee, Nanae Matsumoto, Akinori Nakamura, Hisashi Noma, Takuya Omura, Ayaka Onoyama, Phoebe Scollard, Kazuaki Uchida, Yoko Yokoyama, Hidenori Arai, Takashi Sakurai

Aims: To identify subgroups who may be more likely to respond well to a multidomain intervention among older adults with type 2 diabetes.

Materials and methods: This study was a secondary analysis of the Japan Multimodal Intervention Trial for Prevention of Dementia. A total 531 participants aged 65-85 years with mild cognitive impairment were randomized into intervention (vascular risk management, exercise, nutritional counseling, and cognitive training) and control (health-related information) groups. The outcome was the change in average Z scores of neuropsychological tests from baseline to 18 months. Interactions between intervention and age (65-74, 75-85 years), memory impairment (amnestic, nonamnestic), HbA1c levels (within, outside target range), or APOE genotype (0, ≥1 APOE ε4 alleles) among participants with diabetes were evaluated using the mixed-effects model for repeated measures.

Results: Among 76 participants with diabetes, a significant age × intervention interaction (P = 0.007) was found, which was driven by benefits in the younger age group (Z score difference: 0.33, 95% CI: 0.09 to 0.55) that were not observed in the older age group. Intervention benefits were also detected in those with HbA1c levels outside the target range (Z score difference: 0.31, 95% CI: 0.06 to 0.56), with HbA1c levels × intervention interaction (P = 0.021). No significant interactions were detected between intervention and memory impairment or APOE genotype.

Conclusions: Multidomain interventions may benefit younger older adults or those with overly strict or lenient HbA1c control; however, these findings need confirmation in future studies.

目的:确定对老年2型糖尿病患者多领域干预反应良好的亚组。材料和方法:本研究是对日本预防痴呆多模式干预试验的二次分析。531名年龄在65-85岁的轻度认知障碍参与者被随机分为干预组(血管风险管理、运动、营养咨询和认知训练)和对照组(健康相关信息)。结果是神经心理测试的平均Z分数从基线到18个月的变化。使用重复测量的混合效应模型评估干预与糖尿病参与者的年龄(65-74岁、75-85岁)、记忆障碍(健忘症、非健忘症)、HbA1c水平(在目标范围内、目标范围外)或APOE基因型(0、≥1个APOE ε4等位基因)之间的相互作用。结果:在76名糖尿病患者中,发现了显著的年龄×干预相互作用(P = 0.007),这是由于年轻年龄组的益处(Z评分差:0.33,95% CI: 0.09至0.55),而在老年组中没有观察到。在HbA1c水平超出目标范围的患者中也发现了干预的益处(Z评分差:0.31,95% CI: 0.06至0.56),HbA1c水平与干预的相互作用(P = 0.021)。干预与记忆障碍或APOE基因型之间没有发现显著的相互作用。结论:多领域干预可能有利于年轻的老年人或对HbA1c控制过于严格或宽松的老年人;然而,这些发现需要在未来的研究中得到证实。
{"title":"Multidomain interventions for preventing cognitive decline in older adults with type 2 diabetes and mild cognitive impairment: Secondary analysis of the J-MINT: Multidomain intervention in type 2 diabetes.","authors":"Taiki Sugimoto, Paul K Crane, Seo-Eun Choi, Kosuke Fujita, Jeanne Gallée, Yujiro Kuroda, Michael Lee, Nanae Matsumoto, Akinori Nakamura, Hisashi Noma, Takuya Omura, Ayaka Onoyama, Phoebe Scollard, Kazuaki Uchida, Yoko Yokoyama, Hidenori Arai, Takashi Sakurai","doi":"10.1016/j.jarlif.2025.100016","DOIUrl":"10.1016/j.jarlif.2025.100016","url":null,"abstract":"<p><strong>Aims: </strong>To identify subgroups who may be more likely to respond well to a multidomain intervention among older adults with type 2 diabetes.</p><p><strong>Materials and methods: </strong>This study was a secondary analysis of the Japan Multimodal Intervention Trial for Prevention of Dementia. A total 531 participants aged 65-85 years with mild cognitive impairment were randomized into intervention (vascular risk management, exercise, nutritional counseling, and cognitive training) and control (health-related information) groups. The outcome was the change in average Z scores of neuropsychological tests from baseline to 18 months. Interactions between intervention and age (65-74, 75-85 years), memory impairment (amnestic, nonamnestic), HbA1c levels (within, outside target range), or <i>APOE</i> genotype (0, ≥1 <i>APOE</i> ε4 alleles) among participants with diabetes were evaluated using the mixed-effects model for repeated measures.</p><p><strong>Results: </strong>Among 76 participants with diabetes, a significant age × intervention interaction (<i>P</i> = 0.007) was found, which was driven by benefits in the younger age group (Z score difference: 0.33, 95% CI: 0.09 to 0.55) that were not observed in the older age group. Intervention benefits were also detected in those with HbA1c levels outside the target range (Z score difference: 0.31, 95% CI: 0.06 to 0.56), with HbA1c levels × intervention interaction (<i>P</i> = 0.021). No significant interactions were detected between intervention and memory impairment or <i>APOE</i> genotype.</p><p><strong>Conclusions: </strong>Multidomain interventions may benefit younger older adults or those with overly strict or lenient HbA1c control; however, these findings need confirmation in future studies.</p>","PeriodicalId":73537,"journal":{"name":"JAR life","volume":"14 ","pages":"100016"},"PeriodicalIF":0.0,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12181009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144369622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stand if you can- A parallel, superiority cluster randomized controlled trial to improve gait speed for long term care residents. 站立,如果你可以——一个平行的,优势集群随机对照试验,以改善长期护理居民的步态速度。
Pub Date : 2025-05-09 eCollection Date: 2025-01-01 DOI: 10.1016/j.jarlif.2025.100015
Kendra Cooling, Danielle R Bouchard, Molly Gallibois, Jeffrey Hebert, Martin Sénéchal, Pamela Jarrett, Chris McGibbon, Emily Richard, Grant Handrigan

Objective: To examine the effects of a standing intervention on gait speed for older adults living in long term care (LTC) residences.

Design: A parallel superiority cluster randomized controlled trial.

Setting and participants: LTC residences. A total of 95 LTC residents (n = 47 control; n = 48 intervention) participated in the study.

Methods: LTC residences and therefore the residents from the homes were randomized to either the intervention group (standing up to 100 minutes/week) for 22 weeks or the control group (socializing with staff with no encouragement to stand for up to 100 minutes/week) for 22 weeks. The primary outcome is gait speed measured by the 10-meter walking speed test.

Results: A total of 95 participants (n= 47 in the control group and n=48 in the intervention group) age 86 ± 8 years completed the trial, averaging 41.9 ± 30.3 min of standing per week in the intervention group and 48.4 ± 22.8 min of time matched activity in the control group. There was no significant difference between groups in changes in gait speed (β=-0.034, 95 % C.I. (-0.097 0.028)).

Conclusions and implications: This 22-week standing intervention did not improve gait speed in older adults living in LTC residences.Trial registration: clinicaltrials.gov - NCT03796039.

目的:研究站立干预对长期护理(LTC)老年人步态速度的影响。设计:平行优势群随机对照试验。环境和参与者:LTC住宅。共有95名LTC居民(n = 47对照组;N = 48名干预者)参与研究。方法:LTC住宅和来自家庭的居民被随机分配到干预组(每周站立100分钟)22周或对照组(与工作人员社交,不鼓励站立100分钟/周)22周。主要结果是通过10米步行速度测试测量的步态速度。结果:共有95名年龄为86±8岁的参与者(对照组n= 47,干预组n=48)完成了试验,干预组平均每周站立时间为41.9±30.3分钟,对照组平均每周站立时间为48.4±22.8分钟。两组间步态速度变化无显著性差异(β=-0.034, 95% C.I.(-0.097 0.028))。结论和意义:这项为期22周的站立干预并没有改善居住在LTC住宅的老年人的步态速度。试验注册:clinicaltrials.gov - NCT03796039。
{"title":"Stand if you can- A parallel, superiority cluster randomized controlled trial to improve gait speed for long term care residents.","authors":"Kendra Cooling, Danielle R Bouchard, Molly Gallibois, Jeffrey Hebert, Martin Sénéchal, Pamela Jarrett, Chris McGibbon, Emily Richard, Grant Handrigan","doi":"10.1016/j.jarlif.2025.100015","DOIUrl":"10.1016/j.jarlif.2025.100015","url":null,"abstract":"<p><strong>Objective: </strong>To examine the effects of a standing intervention on gait speed for older adults living in long term care (LTC) residences.</p><p><strong>Design: </strong>A parallel superiority cluster randomized controlled trial.</p><p><strong>Setting and participants: </strong>LTC residences. A total of 95 LTC residents (n = 47 control; n = 48 intervention) participated in the study.</p><p><strong>Methods: </strong>LTC residences and therefore the residents from the homes were randomized to either the intervention group (standing up to 100 minutes/week) for 22 weeks or the control group (socializing with staff with no encouragement to stand for up to 100 minutes/week) for 22 weeks. The primary outcome is gait speed measured by the 10-meter walking speed test.</p><p><strong>Results: </strong>A total of 95 participants (n= 47 in the control group and n=48 in the intervention group) age 86 ± 8 years completed the trial, averaging 41.9 ± 30.3 min of standing per week in the intervention group and 48.4 ± 22.8 min of time matched activity in the control group. There was no significant difference between groups in changes in gait speed (β=-0.034, 95 % C.I. (-0.097 0.028)).</p><p><strong>Conclusions and implications: </strong>This 22-week standing intervention did not improve gait speed in older adults living in LTC residences.Trial registration: clinicaltrials.gov - NCT03796039.</p>","PeriodicalId":73537,"journal":{"name":"JAR life","volume":"14 ","pages":"100015"},"PeriodicalIF":0.0,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12136834/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144227872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Building a brain watch: Crafting Accurate and High-Precision Personalized Plans for Optimal Brain Performance and Sustained Functionality. 构建大脑手表:为最佳大脑表现和持续功能精心制作准确和高精度的个性化计划。
Pub Date : 2025-04-18 eCollection Date: 2025-01-01 DOI: 10.1016/j.jarlif.2025.100013
Ara S Khachaturian
{"title":"Building a brain watch: Crafting Accurate and High-Precision Personalized Plans for Optimal Brain Performance and Sustained Functionality.","authors":"Ara S Khachaturian","doi":"10.1016/j.jarlif.2025.100013","DOIUrl":"https://doi.org/10.1016/j.jarlif.2025.100013","url":null,"abstract":"","PeriodicalId":73537,"journal":{"name":"JAR life","volume":"14 ","pages":"100013"},"PeriodicalIF":0.0,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12036018/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144055337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JAR life
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1